AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
GE HealthCare’s next-generation MRI push shows imaging AI is becoming infrastructure
GE HealthCare says its next-gen SIGNA MR technology is helping advance research and translate innovation into clinical impact. The announcement reflects a broader shift in imaging: AI-enabled MRI is no longer just about faster scans, but about creating platforms that support discovery and downstream clinical use.
DeepTek and deepc Push Radiology AI Closer to the Workflow Layer
DeepTek and deepc are teaming up to integrate radiology AI tools more directly into clinical workflow. The partnership reflects a broader industry shift: the winning AI products may be the ones radiologists barely notice because they sit inside existing systems.
Covera Health and Medmo Merge to Build an End-to-End Imaging Platform
Fierce Healthcare reports that Covera Health and Medmo are combining to create a more complete diagnostic imaging platform. The deal underscores a wider industry push to unify access, navigation, and clinical decision support around imaging.
Amazon Turns AWS Into an AI Drug Discovery Platform
Amazon’s latest push into biotechnology signals that cloud infrastructure is becoming a productized drug discovery stack, not just compute rented by the hour. The move raises the stakes for every platform player trying to own the workflow from target identification to candidate design.
Amazon’s AI Drug Discovery Push Turns the Cloud Giant Into a Biotech Platform
Amazon’s new Bio Discovery platform marks a serious attempt to bring its cloud and AI infrastructure into the center of pharmaceutical research. The launch also underscores how rapidly the AI drug discovery market is becoming a platform contest among tech giants and specialized life sciences vendors.
MedPal AI’s Closed-Loop Platform Points to a More Operational Era for Digital Health
MedPal AI surged after unveiling a closed-loop digital health platform, suggesting investors are rewarding products that move beyond engagement and into measurable workflow execution. The platform appears aimed at connecting recommendations, follow-up, and outcomes in one system.
Variational AI updates Enki 4 as competition intensifies in foundation-model drug discovery
Variational AI has released Enki 4, a major update to its foundation model for small-molecule discovery. The launch reflects a fast-moving race to turn foundation models into repeatable productivity engines for medicinal chemistry rather than one-off demo systems.
AI drug discovery shifts from single models to multi-agent systems
Databricks has entered the drug discovery arena with AiChemy, a multi-agent AI system aimed at coordinating more of the discovery workflow rather than simply optimizing one step. The move reflects a broader industry pivot: the bottleneck is no longer generating ideas, but orchestrating them across fragmented data, tools, and teams.
AI Drug Discovery Platforms Are Shifting From Promises to Infrastructure
A new wave of platform launches underscores how drug discovery is becoming a systems-level AI market. Rather than selling a single model, companies are now packaging data, automation, and decision support into integrated discovery engines aimed at global disease burdens.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.